UPDATE: Sarepta Therapeutics (SRPT) Initiated Buy at UBS
Tweet
Share
E-mail
Get Alerts SRPT Hot Sheet
Price: $18.96 -1.35%
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
(Updated - October 27, 2020 5:04 PM EDT)
UBS analyst Colin Bristow starts Sarepta Therapeutics (NASDAQ: SRPT)at Buy, PT $266.00
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Keefe, Bruyette & Woods Resumes Royal Bank of Canada (RY:CN) (RY) at Market Perform
- BNP Paribas Exane Starts NIQ Global Intelligence Plc (NIQ) at Outperform
Create E-mail Alert Related Categories
New CoverageRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
